SMARTphone-Based Cardiovascular Risk Reduction Program in BREAST Cancer Patients [SMART-BREAST]: A Multi-Centre Randomized Controlled Trial

Not Applicable

Active, not recruiting

• Conditions: Cardiovascular disease; Breast Cancer; Cardiovascular - Other cardiovascular diseases; Cancer - Breast

• Registration Number: ACTRN12620000007932
• Lead Sponsor: Cardiology Department - Austin Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-01-08
• Last Update Posted: 5 July 2021

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: Female
• Target Recruitment: 104

Inclusion Criteria

Patients over the age of 18 with a diagnosis of breast cancer treated with any modality. The other major inclusion criteria will be personal ownership of a smartphone.

Exclusion Criteria

Patients with metastatic disease and patients with a prognosis of less than 6 months as determined by their treating oncologist at the time of diagnosis. Patients who are unable to give informed consent, cannot communicate in written English will also be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is a change in exercise capacity (measured by six-minute walk test distance).[12 months]